Moderna Stock Rises, But FDA Declines To Push For Covid Booster Shot Ahead Of Key Meeting

Moderna Stock Rises, But FDA Declines To Push For Covid Booster Shot Ahead Of Key Meeting
·2 min read

Moderna stock rose Tuesday even after the Food and Drug Administration held off recommending a booster dose of the company's Covid shot.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting